# AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

> **NCT07720271** · PHASE3 · RECRUITING · sponsor: **Novo Nordisk A/S** · enrollment: 950 (estimated)

## Conditions studied

- Overweight
- Obesity

## Interventions

- **DRUG:** zenagamtide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07720271
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-08-31
- **Primary completion:** 2028-06-27
- **Final completion:** 2028-08-22
- **Target enrollment:** 950 (ESTIMATED)
- **Last updated:** 2026-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07720271

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07720271, "AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07720271. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*